Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial-Reference-Cited by-同舟云学术

Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial

Published:2021-05 Issue:10 Volume:10 Page:3240-3248
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Yokomizo Akira¹²^ORCID,Koga Hirofumi¹²,Ito Kazuto³^ORCID,Takezawa Yutaka⁴,Komiyama Motokiyo⁵,Nishimura Kazuo⁶,Yonese Junji⁷,Hashine Katsuyoshi⁸,Masumori Naoya⁹,Arai Gaku¹⁰,Saito Shiro¹¹,Shinohara Mitsuru¹²,Shimizu Nobuaki¹³,Yamauchi Atsushi¹⁴,Satoh Takefumi¹⁵,Tochigi Tatsuo¹⁶,Kobayashi Mikio⁴,Fujimoto Hiroyuki⁵,Kakimoto Ken‐ichi⁶,Fukui Iwao⁷,Tsukamoto Taiji¹⁷,Nozaki Miwako¹⁸,Karasawa Katsuyuki¹⁹,Hasumi Masaru¹³,Ohtani Mikinobu¹⁴,Ishiyama Hiromichi²⁰,Kuwahara Masaaki²¹,Harada Masaoki²²,Ohashi Yasuo²³,Kotake Toshihiko²⁴,Kakizoe Tadao²⁵,Suzuki Kazuhiro³,Naito Seiji¹,Yamanaka Hidetoshi²⁶,Ohyama Atsuko,Ohashi Yasuo,Harada Masaoki,Yamamoto T,Miyakubo M,Fujizuka Y,Akimoto T,Mitsuhashi N,Ishikawa H,Matsuoka N,Sumi M,Ito Y,Hamano T,Tabata K,Tsumura H,Iwamura M,Komori S,Hayakawa K,Kitano M,

Affiliation:

1. Department of Urology Graduate School of Medicine Kyusyu University Fukuoka Japan

2. Department of Urology Harasanshin Hospital Fukuoka Japan

3. Department of Urology Gunma University Graduate School of Medicine Maebashi Japan

4. Department of Urology Isesaki Municipal Hospital Isesaki Japan

5. Department of Urology National Cancer Center Hospital Tokyo Japan

6. Department of Urology Osaka International Cancer Institute Osaka Japan

7. Department of Urology Cancer Institute Hospital Tokyo Japan

8. Department of Urology Shikoku Cancer Center Matsuyama Japan

9. Department of Urology Sapporo Medical University School of Medicine Sapporo Japan

10. Department of Urology Dokkyo University Koshigaya Hospital Koshigaya Japan

11. Department of Urology Tokyo Medical Center Tokyo Japan

12. Department of Urology Tokyo Metropolitan Komagome Hospital Tokyo Japan

13. Department of Urology Gunma Cancer Center Hospital Ohta Japan

14. Department of Urology Ibaraki Prefectural Central Hospital Kasama Japan

15. Department of Urology Kitasato University School of Medicine Sagamihara Japan

16. Department of Urology Miyagi Cancer Center Natori Japan

17. Sapporo Medical University School of Medicine Sapporo Japan

18. Department of Radiation Oncology Dokkyo University Koshigaya Hospital Koshigaya Japan

19. Department of Radiation Oncology Tokyo Metropolitan Komagome Hospital Tokyo Japan

20. Department of Radiation and Radiation Oncology Kitasato University Sagamihara Japan

21. Sendai Jin‐hinyokika Sendai Japan

22. Kanagawa Cancer Center Yokohama Japan

23. University of Tokyo Tokyo Japan

24. Kotake Clinic Osaka Japan

25. President, Japan Cancer Society Tokyo Japan

26. Institute for Preventive Medicine Kurosawa Hospital Takasaki Japan

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3895

Reference20 articles.

1. International Variation in Prostate Cancer Incidence and Mortality Rates

2. Prostate cancer in Asian men

3. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

4. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer

5. Treatment of Prostate Cancer With Intermittent Versus Continuous Androgen Deprivation: A Systematic Review of Randomized Trials

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal study;Radiation Oncology;2022-05-12

2. Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain;F1000Research;2022-04-21

3. Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain;F1000Research;2021-10-21